المؤلفون: Delimpasi, Sosana, Dimopoulos, Meletios A., Straub, Jan, Symeonidis, Argiris, Pour, Luděk, Hájek, Roman, Touzeau, Cyrille, Bhanderi, Viralkumar K., Berdeja, Jesus G., Pavlíček, Petr, Matous, Jeffrey V., Robak, Pawel J., Suryanarayan, Kaveri, Miller, Alison, Villarreal, Miguel, Cherepanov, Dasha, Srimani, Jaydeep K., Yao, Huilan, Labotka, Richard, Orlowski, Robert Z.

المصدر: American Journal of Hematology ; ISSN 0361-8609 1096-8652

الإتاحة: https://doi.org/10.1002/ajh.27382Test

المؤلفون: Richardson, Paul G., Facon, Thierry, Venner, Christopher P., Bahlis, Nizar J., Offner, Fritz, White, Darrell, Karlin, Lionel, Benboubker, Lotfi, Voog, Eric, Yoon, Sung-Soo, Suzuki, Kenshi, Shibayama, Hirohiko, Zhang, Xiaoquan, Villarreal, Miguel, Twumasi-Ankrah, Philip, Labotka, Richard, Rifkin, Robert M., Lonial, Sagar, Kumar, Shaji K., Rajkumar, S. Vincent, Moreau, Philippe

المصدر: EJHAEM ; ISSN: 2688-6146

مصطلحات موضوعية: Medicine and Health Sciences, depth of response, ixazomib, multiple myeloma, response kinetics, LENALIDOMIDE, SURVIVAL, KINETICS, THERAPY

وصف الملف: application/pdf

العلاقة: https://biblio.ugent.be/publication/01HYZTXAMK5TTTJXXA7WKKQEMRTest; http://hdl.handle.net/1854/LU-01HYZTXAMK5TTTJXXA7WKKQEMRTest; http://doi.org/10.1002/jha2.759Test; https://biblio.ugent.be/publication/01HYZTXAMK5TTTJXXA7WKKQEMR/file/01HYZTXHV49EQCFMJN7H2WFH32Test

الإتاحة: https://doi.org/10.1002/jha2.759Test
https://biblio.ugent.be/publication/01HYZTXAMK5TTTJXXA7WKKQEMRTest
http://hdl.handle.net/1854/LU-01HYZTXAMK5TTTJXXA7WKKQEMRTest
https://biblio.ugent.be/publication/01HYZTXAMK5TTTJXXA7WKKQEMR/file/01HYZTXHV49EQCFMJN7H2WFH32Test

المؤلفون: Sanchorawala, Vaishali, Wechalekar, Ashutosh DD, Kim, Kihyun, Schönland, Stefan OO, Landau, Heather JJ, Kwok, Fiona, Suzuki, Kenshi, Dispenzieri, Angela, Merlini, Giampaolo, Comenzo, Raymond LL, Cherepanov, Dasha, Hayden, Vanessa CC, Kumar, Arun, Labotka, Richard, Faller, Douglas VV, Kastritis, Efstathios

المصدر: American Journal of Hematology (2023) (In press).

وصف الملف: text

العلاقة: https://discovery.ucl.ac.uk/id/eprint/10167180/1/American%20J%20Hematol%20-%202023%20-%20Sanchorawala%20-%20Quality%20of%20life%20and%20symptoms%20among%20patients%20with%20relapsed%20refractory%20AL.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10167180Test/

الإتاحة: https://discovery.ucl.ac.uk/id/eprint/10167180/1/American%20J%20Hematol%20-%202023%20-%20Sanchorawala%20-%20Quality%20of%20life%20and%20symptoms%20among%20patients%20with%20relapsed%20refractory%20AL.pdfTest
https://discovery.ucl.ac.uk/id/eprint/10167180Test/

المؤلفون: Srimani, Jaydeep K., Diderichsen, Paul M., Hanley, Michael J., Labotka, Richard, Gupta, Neeraj

المصدر: Clinical Pharmacology & Therapeutics ; volume 114, issue 1, page 220-229 ; ISSN 0009-9236 1532-6535

الإتاحة: https://doi.org/10.1002/cpt.2917Test

المؤلفون: Chng, Wee-Joo, Lonial, Sagar, Morgan, Gareth J., Iida, Shinsuke, Moreau, Philippe, Kumar, Shaji K., Twumasi-Ankrah, Philip, Villarreal, Miguel, Dash, Ajeeta B., Vorog, Alexander, Zhang, Xiaoquan, Suryanarayan, Kaveri, Labotka, Richard, Dimopoulos, Meletios A., Rajkumar, S. Vincent

المساهمون: Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited

المصدر: Blood Cancer Journal ; volume 13, issue 1 ; ISSN 2044-5385

مصطلحات موضوعية: Oncology, Hematology

الإتاحة: https://doi.org/10.1038/s41408-022-00768-5Test
https://www.nature.com/articles/s41408-022-00768-5.pdfTest
https://www.nature.com/articles/s41408-022-00768-5Test

المؤلفون: Bringhen, Sara, Pour, Luděk, Benjamin, Reuben, Grosicki, Sebastian, Min, Chang-Ki, C． de Farias, Danielle Leao, Vorog, Alexander, Labotka, Richard J., Wang, Bingxia, Cherepanov, Dasha, Cain, Lauren E., Manne, Sudhakar, Rajkumar, S. Vincent, Dimopoulos, Meletios A.

المساهمون: Takeda Pharmaceutical Company, Millennium Pharmaceuticals Inc

المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 23, issue 7, page 491-504 ; ISSN 2152-2650

مصطلحات موضوعية: Cancer Research, Oncology, Hematology

الإتاحة: https://doi.org/10.1016/j.clml.2023.03.007Test
https://api.elsevier.com/content/article/PII:S2152265023000939?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2152265023000939?httpAccept=text/plainTest

المؤلفون: Paiva, Bruno, Manrique, Irene, Dimopoulos, Meletios A., Gay, Francesca, Min, Chang-Ki, Zweegman, Sonja, Špička, Ivan, Teipel, Raphael, Mateos, María-Victoria, Giuliani, Nicola, Cavo, Michele, Hopkins, Christine Rojas, Fu, Weijun, Suryanarayan, Kaveri, Vorog, Alexander, Li, Cong, Wang, Bingxia, Estevam, Jose, Labotka, Richard, Dash, Ajeeta B.

المصدر: Paiva , B , Manrique , I , Dimopoulos , M A , Gay , F , Min , C-K , Zweegman , S , Špička , I , Teipel , R , Mateos , M-V , Giuliani , N , Cavo , M , Hopkins , C R , Fu , W , Suryanarayan , K , Vorog , A , Li , C , Wang , B , Estevam , J , Labotka , R & Dash , A B 2022 , ' MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the ....

العلاقة: https://research.vumc.nl/en/publications/b5853646-1a48-4958-bade-1e2023a9ccb8Test

الإتاحة: https://doi.org/10.1182/blood.2022016782Test
https://research.vumc.nl/en/publications/b5853646-1a48-4958-bade-1e2023a9ccb8Test
http://www.scopus.com/inward/record.url?scp=85143285106&partnerID=8YFLogxKTest

المؤلفون: Dimopoulos, Meletios A., Schjesvold, Fredrik Hellem, Doronin, Vadim, Vinogradova, Olga, Quach, Hang, Leleu, Xavier, Montes, Yolanda Gonzalez, Ramasamy, Karthik, Pompa, Alessandra, Levin, Mark-David, Lee, Cindy, Mellqvist, Ulf Henrik, Fenk, Roland, Demarquette, Hélène, Sati, Hamdi, Vorog, Alexander, Labotka, Richard, Du, Jichang, Darif, Mohamed, Kumar, Shaji

المصدر: 2044-5385.

العلاقة: Dimopoulos, Meletios A. Schjesvold, Fredrik Hellem Doronin, Vadim Vinogradova, Olga Quach, Hang Leleu, Xavier Montes, Yolanda Gonzalez Ramasamy, Karthik Pompa, Alessandra Levin, Mark-David Lee, Cindy Mellqvist, Ulf Henrik Fenk, Roland Demarquette, Hélène Sati, Hamdi Vorog, Alexander Labotka, Richard Du, Jichang Darif, Mohamed Kumar, Shaji . Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial. Blood Cancer Journal. 2022, 12(1); http://hdl.handle.net/10852/97737Test; 2024467; info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Blood Cancer Journal&rft.volume=12&rft.spage=&rft.date=2022; Blood Cancer Journal; 12; https://doi.org/10.1038/s41408-021-00593-2Test

الإتاحة: https://doi.org/10.1038/s41408-021-00593-2Test
http://hdl.handle.net/10852/97737Test

المؤلفون: Srimani, Jaydeep K., Diderichsen, Paul M., Hanley, Michael J., Venkatakrishnan, Karthik, Labotka, Richard, Gupta, Neeraj

المصدر: CPT: Pharmacometrics & Systems Pharmacology ; volume 11, issue 8, page 1085-1099 ; ISSN 2163-8306 2163-8306

الإتاحة: https://doi.org/10.1002/psp4.12815Test

المؤلفون: Spencer, Andrew, Samoilova, Olga, Chng, Wee‐Joo, Labotka, Richard, Li, Cong, Wu, Kwang‐Wei, Saxena, Nakul, Yan, Xu, Lee, Jae Hoon, Beksac, Meral

المصدر: eJHaem ; volume 3, issue 4, page 1241-1251 ; ISSN 2688-6146 2688-6146

الإتاحة: https://doi.org/10.1002/jha2.548Test